Evidence map›Paper›PMID 11376068›Full record

ArticleJournal of clinical microbiology2001

Strategy for diagnosis of congenital toxoplasmosis: evaluation of methods comparing mothers and newborns and standard methods for postnatal detection of immunoglobulin G, M, and A antibodies.

J M Pinon, H Dumon, C Chemla, J Franck, E Petersen, M Lebech, J Zufferey, M H Bessieres, P Marty, R Holliman and 9 more

Open access · greenAbstract readComparative StudyEvaluation Study
In one paragraph

Article in Journal of clinical microbiology, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 2 pooled it
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 2 syntheses or guidelines pooled it, 165 citations in OpenAlex.

  1. Guideline
  2. Guideline
  3. Trial
  4. Article
  5. Article
  6. La Tunisie medicale · 2025
    Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Maternal Anti-Journal of clinical microbiology · 2021
    Article
  16. Article
  17. Evaluation ofAdvanced biomedical research · 2018
    Article
  18. Laboratory Diagnosis of Congenital Toxoplasmosis.Journal of clinical microbiology · 2016
    Review
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 13 institutions in 4 countries.

J M PinonService de Parasitologie-Mycologie, CHU Hôpital Maison Blanche, UPRES EA 2070, IFR53, 51092, Reims, France.
H Dumon
C Chemla
J Franck
E Petersen
M Lebech
J Zufferey
M H Bessieres
P Marty
R Holliman
J Johnson
V Luyasu
B Lecolier
E Guy
D H Joynson
A Decoster
G Enders
H Pelloux
E Candolfi
Hôpital de la Timone · FRHôpital Maison Blanche · FRSingleton Hospital · GBSt George's Hospital · GBCentre Hospitalier Universitaire de Grenoble · FRClinique Saint Pierre · BEHôpital l'Archet · FRHôpital Rangueil · FRHôpital Saint-Philibert · FRHvidovre Hospital · DKInstitut d’Epidémiologie Neurologique et de Neurologie Tropicale · FRInstitut de Virologie · FRStatens Serum Institut · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In a study involving 14 laboratories supported by the European Community Biomed 2 program, we evaluated immunologic methods for the postnatal diagnosis of congenital toxoplasmosis (CT). Among babies born to mothers who seroconverted to positivity for toxoplasmosis during pregnancy, we analyzed 55 babies with CT on the basis of persistent anti-Toxoplasma immunoglobulin G (IgG) at 1 year of life and 50 control babies without anti-Toxoplasma IgG at 1 year of life in the absence of curative treatment with pyrimethamine-sulfonamides. We tested in-house methods such as the enzyme-linked immunofiltration assay (ELIFA) or Immunoblotting (IB) for the detection of IgG or IgM; these methods allowed comparison of the immunologic profiles of the mothers and the infants. We compared ELIFA and IB with a commercial enzyme immunoassay (EIA) or in-house immunosorbent agglutination assay (ISAGA) for the detection of IgM or IgA. The performances of combinations of methods were also assessed. A cumulative sensitivity of 98% during a 1-year follow-up was obtained with the ELIFA plus ISAGA combination. Only one case of CT was missed by the ELIFA plus ISAGA combination, whereas three cases were missed by the IB plus ISAGA combination, even though 48% of patients with CT were treated with pyrimethamine-sulfonamides, which are known to inhibit antibody neosynthesis. A similar performance was obtained with either ELIFA or IB in combination with EIA. The difference in performance between ELIFA plus ISAGA and IB plus ISAGA was not statistically significant (P = 0.31), and we conclude that both combinations of tests can be used for the diagnosis of CT in newborns.

Indexed as

Neonatal ScreeningAdultAnimalsAntibodies, ProtozoanFemaleHumansImmunoglobulin AImmunoglobulin GImmunoglobulin MImmunologic TestsInfant, NewbornToxoplasmaToxoplasmosis, CongenitalAntibodies, ProtozoanImmunoglobulin AImmunoglobulin GImmunoglobulin M

Identifiers

PMID11376068
PMCPMC88122
OpenAlexW2102996948

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.